As of November 2024, Nanjing Vazyme Biotech has a market cap of $1.00B. This makes Nanjing Vazyme Biotech the world's 7853th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.43B | -20.80% |
2023 | $1.81B | -28.46% |
2022 | $2.53B | -15.63% |
2021 | $3.00B | 11.92% |
2020 | $2.68B | 2.16% |
2019 | $2.62B | -1.84% |
2018 | $2.67B | 0.38% |
2017 | $2.66B | 36.08% |
2016 | $1.95B | -11.13% |
2015 | $2.20B | 60.92% |
2014 | $1.37B | -3.26% |
2013 | $1.41B | 18.89% |
2012 | $1.19B | - |